MiniMed Group, Inc.
Research MiniMed Group, Inc. (MMED) on Bullrun: market cap USD 5.28B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMMED
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 5.28B
- Financial periodFY2026
- RevenueUSD 3.10B
- Revenue growth14.3%
- Net income-USD 333.00M
- Free cash flow-USD 420.00M
- Gross margin54.2%
Valuation Snapshot
latest market cap is USD 5.28B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 3.10B | -USD 333.00M | -USD 420.00M | 54.2% | -1.3 | USD 298.00M | USD 145.00M | USD 3.61B |
| FY2025 | USD 2.72B | -USD 213.00M | -USD 53.00M | 56.3% | -0.76 | USD 11.00M | USD 11.00M | USD 3.33B |
| FY2024 | USD 2.47B | -USD 112.00M | -USD 107.00M | 58.2% | -0.4 | USD 54.00M | USD 8.00M | USD 3.45B |
| FY2023 | USD 2.25B | -USD 96.00M | -USD 173.00M | 58.3% | -0.34 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 5.28B | n/a | n/a | n/a |
About MiniMed Group, Inc.
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MiniMed Group, Inc.'s market cap?
MiniMed Group, Inc.'s market capitalization is USD 5.28B.
What does MiniMed Group, Inc. do?
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D.